BeOne Medicines Ownership & Insider Activity

BeOne Medicines (ONC) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 0.3% of shares outstanding. Institutional investors hold 24.2%. Over the past 90 days, insiders made 7 sales worth $100.0M.

Shares Outstanding

113.122M

Shares Float

80.360M

Insider Shares Owned

3.845M

Insider % Owned

0.3%

Institutional Shares Held

27.517M

Institutional % Held

24.2%

Ownership Breakdown

Net Insider Activity by Month

Purchases (90d)

Sales (90d)

$100.0M total

Net Activity

Net Selling

Net Value (90d)

-$100.0M

BeOne Medicines Insider Transactions (Last 6 Months)

모든 내부자 거래 내역 보기 →

Date	Insider	Title	Type	Shares	Price	Value
Oct 13, 2026	Xiaodong Wang	DIRECTOR	SELL-OPTIONS	—	$193.94	$9.7M
Sep 30, 2026	Henry Chan Lee	SVP, GENERAL COUNSEL	SELL	1.115K	$375.00	$418K
Sep 28, 2026	Xiaodong Wang	DIRECTOR	SELL-OPTIONS	—	$200.84	$10.2M
Sep 8, 2026	Xiaodong Wang	DIRECTOR	SELL	7.260K	$193.00	$12.2M
Sep 1, 2026	Titus Ball	PRINCIPAL ACCOUNTING OFFICER	SELL	132.000	$355.86	$47K
Aug 25, 2026	Xiaobin Wu	PRESIDENT AND COO	SELL	280.000	$380.00	$106K
Aug 11, 2026	Henry Chan Lee	SVP, GENERAL COUNSEL	SELL-OPTIONS	—	$275.68	$450K
Aug 10, 2026	JOHN OYLER	CHIEF EXECUTIVE OFFICER	SELL	240.810K	$359.12	$86.5M
Aug 3, 2026	Aaron Rosenberg	CHIEF FINANCIAL OFFICER	SELL	1.157K	$312.71	$362K
Jul 30, 2026	Chan Henry Lee	SVP, GENERAL COUNSEL	SELL	1.044K	$323.69	$338K
Jul 22, 2026	Chan Henry Lee	SVP, GENERAL COUNSEL	SELL-OPTIONS	—	$258.29	$223K
Jul 20, 2026	JOHN OYLER	CHIEF EXECUTIVE OFFICER	SELL	75.723K	$217.62	$30.5M
Jul 17, 2026	JOHN OYLER	CHIEF EXECUTIVE OFFICER	SELL-OPTIONS	—	$215.98	$12.4M
Jul 15, 2026	JOHN OYLER	CHIEF EXECUTIVE OFFICER	SELL-OPTIONS	—	$230.42	$48.2M
Jul 14, 2026	JOHN OYLER	CHIEF EXECUTIVE OFFICER	SELL	12.261K	$180.01	$37.4M
Jul 10, 2026	JOHN OYLER	CHIEF EXECUTIVE OFFICER	SELL-OPTIONS	—	$170.04	$16.0M
Jul 8, 2026	Chan Henry Lee	SVP, GENERAL COUNSEL	SELL-OPTIONS	—	$247.01	$74K
Jun 23, 2026	Xiaobin Wu	PRESIDENT AND COO	SELL	1.292K	$276.26	$357K
Jun 23, 2026	JOHN OYLER	CHIEF EXECUTIVE OFFICER	SELL	3.410K	$273.78	$934K
Jun 23, 2026	Lai Wang	PRESIDENT, GLOBAL HEAD R&D	SELL	1.068K	$276.74	$296K
Jun 16, 2026	Xiaobin Wu	PRESIDENT AND COO	SELL	1.357K	$266.76	$362K
Jun 16, 2026	JOHN OYLER	CHIEF EXECUTIVE OFFICER	SELL	3.693K	$265.55	$981K
Jun 16, 2026	Henry Chan Lee	SVP, GENERAL COUNSEL	SELL	590.000	$265.98	$157K
Jun 16, 2026	Lai Wang	PRESIDENT, GLOBAL HEAD R&D	SELL	1.169K	$265.39	$310K
Jun 11, 2026	Titus Ball	PRINCIPAL ACCOUNTING OFFICER	GRANT	31.044K	$257.20	$43K
Jun 11, 2026	Lai Wang	PRESIDENT, GLOBAL HEAD R&D	GRANT	117.869K	$261.00	$197K
Jun 11, 2026	Aaron Rosenberg	CHIEF FINANCIAL OFFICER	GRANT	70.544K	$257.74	$163K
Jun 11, 2026	Xiaobin Wu	PRESIDENT AND COO	GRANT	117.999K	$261.20	$164K
Jun 11, 2026	Henry Chan Lee	SVP, GENERAL COUNSEL	GRANT	44.643K	$257.63	$110K
Jun 11, 2026	JOHN OYLER	CHIEF EXECUTIVE OFFICER	GRANT	175.982K	$257.24	$501K
Jun 8, 2026	Titus Ball	PRINCIPAL ACCOUNTING OFFICER	SELL	136.000	$271.33	$37K
Jun 8, 2026	Henry Chan Lee	SVP, GENERAL COUNSEL	SELL	871.000	$270.42	$236K
Jun 8, 2026	Lai Wang	PRESIDENT, GLOBAL HEAD R&D	SELL	1.367K	$269.38	$368K
Jun 8, 2026	Xiaobin Wu	PRESIDENT AND COO	SELL	1.484K	$269.37	$400K
Jun 8, 2026	JOHN OYLER	CHIEF EXECUTIVE OFFICER	SELL	4.940K	$270.56	$1.3M
Jun 1, 2026	Qingqing Yi	DIRECTOR	SELL	235.000	$279.13	$66K
May 22, 2026	Alessandro Riva	DIRECTOR	SELL	212.000	$309.51	$66K
May 22, 2026	Margaret Dugan	DIRECTOR	SELL	212.000	$309.60	$66K
May 22, 2026	Corsee Corazon Sanders	DIRECTOR	SELL	212.000	$309.59	$66K
May 22, 2026	BAKER BROS ADVISORS LP, LP, Baker Bros Advisors GP LLC, Baker Brothers Life Sciences LP, FELIX BAKER, JULIAN BAKER	—	SELL	10.998K	$23.82	$262K
May 13, 2026	Henry Chan Lee	SVP, GENERAL COUNSEL	SELL-OPTIONS	—	$251.14	$40K

More with Benzinga EdgeGet Access

BeOne Medicines Ltd

뉴스

파트너 / 기고자

벤징가 글로벌

BeOne Medicines Ownership & Insider Activity

BeOne Medicines Insider Transactions (Last 6 Months)

People Also Watch

People Also Watch